Patients with a positive fecal immunochemistry test (FIT) were shown to be at significantly greater risk of developing psoriasis than those with FIT-negative tests. The fecal immunochemistry test (FIT ...

In a recent study published in The Lancet Regional Health Europe, researchers investigated the use of fecal testing and colonoscopies for colorectal cancer (CRC) screening. They also examined factors ...

Commercially available noninvasive screening tests for colorectal cancer - a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard ®) - are equally effective for ...

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

About The Study: In this nested case-control study, completing fecal immunochemical test was associated with a lower risk of overall death from colorectal cancer, particularly in the left colon, and ...

Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new research ...

A fecal lactoferrin test can detect intestinal inflammation. High lactoferrin levels in stool suggest that inflammation is present. This may indicate a bacterial infection or inflammatory bowel ...

Doctors check poop for DNA as part of the screening process for colorectal cancer. It helps doctors diagnose people with this disease during its early stages or even when the cells are precancerous.

Inflammatory bowel disease (IBD), affecting an estimated 6–8 million people worldwide, may soon be monitored with a simple ...